2012年1--6月
编制单位:山东鲁抗医药股份有限公司 单位:元 币种:人民币
项目 | 本期金额 | 上年同期金额 |
归属于母公司股东权益 | 少数股东权益 | 所有者权益合计 | 归属于母公司股东权益 | 少数股东权益 | 所有者权益合计 |
股本 | 资本公积 | 减:库
存股 | 专项
储备 | 盈余公积 | 一般风
险准备 | 未分配利润 | 其他 | | | 股本 | 资本公积 | 减:库
存股 | 专项
储备 | 盈余公积 | 一般风险准备 | 未分配利润 | 其他 | | |
一、上年年末余额 | 581,575,475.00 | 681,053,363.14 | - | - | 150,607,278.74 | - | 249,536,367.19 | - | 30,797,019.05 | 1,693,569,503.12 | 581,575,475.00 | 681,942,083.14 | - | - | 150,607,278.74 | - | 234,523,298.91 | - | 27,998,730.68 | 1,676,646,866.47 |
加:会计政策变更 | | | | | | | | | | - | | | | | | | | | | - |
前期差错更正 | | | | | | | | | | - | | | | | | | | | | - |
其他 | | | | | | | | | | - | | | | | | | | | | - |
二、本年年初余额 | 581,575,475.00 | 681,053,363.14 | - | - | 150,607,278.74 | - | 249,536,367.19 | - | 30,797,019.05 | 1,693,569,503.12 | 581,575,475.00 | 681,942,083.14 | - | - | 150,607,278.74 | - | 234,523,298.91 | - | 27,998,730.68 | 1,676,646,866.47 |
三、本期增减变动金额(减少以“-”号填列) | - | 106,260.00 | - | - | - | - | -71,461,198.98 | - | 20,438,402.14 | -50,916,536.84 | - | 96,600.00 | - | - | - | - | 56,434,518.61 | - | 2,266,244.35 | 58,797,362.96 |
(一)净利润 | | | | | | | -71,461,198.98 | | 2,538,144.64 | -68,923,054.34 | | | | | | | 56,434,518.61 | | 2,266,244.35 | 58,700,762.96 |
(二)其他综合收益 | | 106,260.00 | | | | | | | | 106,260.00 | | 96,600.00 | | | | | | | | 96,600.00 |
上述(一)和(二)小计 | - | 106,260.00 | - | - | - | - | -71,461,198.98 | - | 2,538,144.64 | -68,816,794.34 | - | 96,600.00 | - | - | - | - | 56,434,518.61 | - | 2,266,244.35 | 58,797,362.96 |
(三)股东投入和减少资本 | - | - | - | - | - | - | - | - | 17,900,257.50 | 17,900,257.50 | - | - | - | - | - | - | - | - | - | - |
1、股东投入资本 | | | | | | | | | | - | | | | | | | | | | - |
2、股份支付计入股东权益的金额 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
3、其他 | - | | - | - | - | - | - | - | 17,900,257.50 | 17,900,257.50 | - | | - | - | - | - | - | - | - | - |
(四)利润分配 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
1、提取盈余公积 | | | | | | | - | | | - | | | | | | | - | | | - |
2、提取一般风险准备 | | | | | | | | | | - | | | | | | | | | | - |
3、对股东的分配 | | | | | | | | | | - | | | | | | | | | | - |
4、其他 | | | | | | | | | | - | | | | | | | | | | - |
(五)股东权益内部结转 | | | | | | | | | | - | | | | | | | | | | - |
1、资本公积转增股本 | | | | | | | | | | - | | | | | | | | | | - |
2、盈余公积转增股本 | | | | | | | | | | - | | | | | | | | | | - |
3、盈余公积弥补亏损 | | | | | | | | | | - | | | | | | | | | | - |
4、其他 | | | | | | | | | | - | | | | | | | | | | - |
(六)专项储备 | | | | | | | | | | - | | | | | | | | | | - |
1、本期提取 | | | | | | | | | | - | | | | | | | | | | - |
2、本期使用 | | | | | | | | | | - | | | | | | | | | | - |
四、本期期末余额 | 581,575,475.00 | 681,159,623.14 | - | - | 150,607,278.74 | - | 178,075,168.21 | - | 51,235,421.19 | 1,642,652,966.28 | 581,575,475.00 | 682,038,683.14 | - | - | 150,607,278.74 | - | 290,957,817.52 | - | 30,264,975.03 | 1,735,444,229.43 |
法定代表人:高祥友 主管会计工作负责人:李红 会计机构负责人:杨卫华
母公司股东权益变动表
2012年1--6月
编制单位:山东鲁抗医药股份有限公司 单位:元 币种:人民币
项目 | 本期金额 | 上期金额 |
股本 | 资本公积 | 减:库
存股 | 专项储备 | 盈余公积 | 一般风
险准备 | 未分配
利润 | 所有者权益合计 | 股本 | 资本公积 | 减:库
存股 | 专项储备 | 盈余公积 | 一般风
险准备 | 未分配
利润 | 所有者权益合计 |
一、上年年末余额 | 581,575,475.00 | 678,463,318.74 | - | - | 149,762,847.27 | - | 143,556,917.54 | 1,553,358,558.55 | 581,575,475.00 | 679,352,038.74 | - | - | 149,762,847.27 | - | 176,966,138.76 | 1,587,656,499.77 |
加:会计政策变更 | | | | | | | | - | | | | | | | | - |
前期差错更正 | | | | | | | | - | | | | | | | | - |
其他 | | | | | | | | - | | | | | | | | - |
二、本年年初余额 | 581,575,475.00 | 678,463,318.74 | - | - | 149,762,847.27 | - | 143,556,917.54 | 1,553,358,558.55 | 581,575,475.00 | 679,352,038.74 | - | - | 149,762,847.27 | - | 176,966,138.76 | 1,587,656,499.77 |
三、本期增减变动金额(减少以“-”号填列) | - | 106,260.00 | - | - | - | - | -83,482,889.61 | -83,376,629.61 | - | 96,600.00 | - | - | - | - | 33,207,888.50 | 33,304,488.50 |
(一)净利润 | | | | | | | -83,482,889.61 | -83,482,889.61 | | | | | | | 33,207,888.50 | 33,207,888.50 |
(二)其他综合收益 | | 106,260.00 | | | | | | 106,260.00 | | 96,600.00 | | | | | | 96,600.00 |
上述(一)和(二)小计 | - | 106,260.00 | - | - | - | - | -83,482,889.61 | -83,376,629.61 | - | 96,600.00 | - | - | - | - | 33,207,888.50 | 33,304,488.50 |
(三)股东投入和减少资本 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
1、股东投入资本 | | | | | | | | - | | | | | | | | - |
2、股份支付计入股东权益的金额 | | | | | | | | - | | | | | | | | - |
3、其他 | | | | | | | | - | | | | | | | | - |
(四)利润分配 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
1、提取盈余公积 | | | | | | | - | - | | | | | | | - | - |
2、提取一般风险准备 | | | | | | | | - | | | | | | | | - |
3、对股东的分配 | | | | | | | | - | | | | | | | | - |
4、其他 | | | | | | | | - | | | | | | | | - |
(五)股东权益内部结转 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
1、资本公积转增股本 | | | | | | | | - | | | | | | | | - |
2、盈余公积转增股本 | | | | | | | | - | | | | | | | | - |
3、盈余公积弥补亏损 | | | | | | | | - | | | | | | | | - |
4、其他 | | | | | | | | - | | | | | | | | - |
(六)专项储备 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
1、本期提取 | | | | | | | | - | | | | | | | | - |
2、本期使用 | | | | | | | | - | | | | | | | | - |
四、本期期末余额 | 581,575,475.00 | 678,569,578.74 | - | - | 149,762,847.27 | - | 60,074,027.93 | 1,469,981,928.94 | 581,575,475.00 | 679,448,638.74 | - | - | 149,762,847.27 | - | 210,174,027.26 | 1,620,960,988.27 |
法定代表人:高祥友 主管会计工作负责人:李红 会计机构负责人:杨卫华